Hasil Pencarian - Dwan‐Ying Chang

  • Menampilkan 1 - 9 hasil dari 9
Perbaiki Hasil
  1. 1
    Vitiligo after immune checkpoint inhibitor therapy in a woman with metastatic melanoma

    Vitiligo after immune checkpoint inhibitor therapy in a woman with metastatic melanoma oleh Ming-Han Yang, Dwan-Ying Chang

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Acute Hyponatremia Complicated with Seizure after Adjuvant Chemotherapy with Cyclophosphamide and Epirubicin in a Breast Cancer Patient

    Acute Hyponatremia Complicated with Seizure after Adjuvant Chemotherapy with Cyclophosphamide and Epirubicin in a Breast Cancer Patient oleh Yun-Chu Lin, Dwan-Ying Chang

    Diterbitkan 2015-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Malignant Pleural Mesothelioma with Extensive Skeletal Muscle Metastasis

    Malignant Pleural Mesothelioma with Extensive Skeletal Muscle Metastasis oleh Chia-Chun Chiang, Ming-Shu Hsieh, Dwan-Ying Chang

    Diterbitkan 2014-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients

    Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients oleh I-Chun Chen, Fu-Chang Hu, Ching-Hung Lin, Shu-Min Huang, Dwan-Ying Chang, Ann-Lii Cheng, Yen-Shen Lu

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis

    Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis oleh Shang‐Hsuan Peng, Ching‐Hung Lin, I‐Chun Chen, Ying‐Chun Shen, Dwan‐Ying Chang, Tom Wei‐Wu Chen, Shu‐Min Huang, Fu‐Chang Hu, Yen‐Shen Lu

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis

    Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐... oleh Ming‐Han Yang, Chiun‐Sheng Huang, Dwan‐Ying Chang, Fu‐Chang Hu, Shu‐Min Huang, Po‐Hsiang Huang, I‐Chun Chen, Tom Wei‐Wu Chen, Ching‐Hung Lin, Yen‐Shen Lu

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women

    A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women oleh Meng-shan Tsai, Shu-Han Chang, Wen-Hung Kuo, Ching-Hua Kuo, Szu-Yi Li, Ming-Yang Wang, Dwan-Ying Chang, Yen-Shen Lu, Chiun-Sheng Huang, Ann-Lii Cheng, Ching-Hung Lin, Pau-Chung Chen

    Diterbitkan 2020-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country.

    High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country. oleh Ching-Hung Lin, Chen-Yang Shen, Jih-Hsiang Lee, Chiun-Sheng Huang, Chih-Hsin Yang, Wen-Hung Kuo, Dwan-Ying Chang, Chia-Ni Hsiung, Kuan-Ting Kuo, Wei-Wu Chen, I-Chun Chen, Pei-Fang Wu, Sung-Hsin Kuo, Chien-Jen Chen, Yen-Shen Lu, Ann-Lii Cheng

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer

    A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer oleh Emi Noguchi, Takashi Yamanaka, Hirofumi Mukai, Naohito Yamamoto, Chi-Feng Chung, Yen-Shen Lu, Dwan-Ying Chang, Joohyuk Sohn, Gun Min Kim, Kyung-Hun Lee, Soo-Chin Lee, Tsutomu Iwasa, Hiroji Iwata, Kenichi Watanabe, Kyung Hae Jung, Yuko Tanabe, Seok Yun Kang, Hiroyuki Yasojima, Kenjiro Aogi, Eriko Tokunaga, Sung Hoon Sim, Yoon Sim Yap, Koji Matsumoto, Ling-Ming Tseng, Yoshiko Umeyama, Kazuki Sudo, Yuki Kojima, Tomomi Hata, Aya Kuchiba, Taro Shibata, Kenichi Nakamura, Yasuhiro Fujiwara, Kenji Tamura, Kan Yonemori

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: